China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion
来源：Reuters发布于 2026-09-24
Chinese drugmaker InnoCare Pharma said on Thursday it entered into a research collaboration and license agreement with Eli Lilly that could be worth up to about $3.35 billion.
相关标的：LLY
本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。